Invention Grant
- Patent Title: 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
-
Application No.: US16138698Application Date: 2018-09-21
-
Publication No.: US10682369B2Publication Date: 2020-06-16
- Inventor: Mark Smith , Klaus G. Klumpp
- Applicant: Riboscience LLC
- Applicant Address: US CA Palo Alto
- Assignee: Riboscience LLC
- Current Assignee: Riboscience LLC
- Current Assignee Address: US CA Palo Alto
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K31/7068
- IPC: A61K31/7068 ; A61K31/7072 ; C07H19/10 ; A61P31/14 ; A61K45/06
Abstract:
Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II, wherein the variables are as described herein, produce a synergistic effect on the inhibition of HCV polymerase.
Public/Granted literature
- US20190231804A1 4'-FLUORO-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION Public/Granted day:2019-08-01
Information query
IPC分类:
